Company Quick10K Filing
Mascota Resources
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-09
10-Q 2019-12-31 Filed 2020-02-19
10-K 2019-09-30 Filed 2020-01-15
10-Q 2019-08-31 Filed 2019-10-21
10-Q 2019-07-01 Filed 2019-07-05
10-Q 2019-02-28 Filed 2019-04-19
S-1 2019-02-26 Public Filing
10-K 2018-11-30 Filed 2019-02-14
10-Q 2018-08-31 Filed 2019-01-04
10-Q 2018-05-31 Filed 2018-11-30
10-Q 2018-02-28 Filed 2018-11-30
10-K 2017-11-30 Filed 2018-08-31
10-Q 2017-08-31 Filed 2017-10-24
10-Q 2017-05-31 Filed 2017-10-19
10-Q 2017-02-28 Filed 2017-08-28
10-K 2016-11-30 Filed 2017-05-15
10-Q 2016-08-31 Filed 2016-11-22
10-Q 2016-05-31 Filed 2016-11-22
10-Q 2016-02-29 Filed 2016-11-22
10-Q 2016-02-28 Filed 2016-11-21
10-K 2015-11-30 Filed 2016-11-08
10-Q 2015-08-31 Filed 2016-11-22
10-Q 2015-05-31 Filed 2016-11-22
10-K 2014-11-30 Filed 2016-07-26
10-Q 2014-08-31 Filed 2015-11-16
10-Q 2014-05-31 Filed 2015-10-23
10-Q 2014-02-28 Filed 2014-07-29
10-K 2013-11-30 Filed 2014-02-12
8-K 2019-12-31
8-K 2019-11-21
8-K 2019-09-30
8-K 2019-09-25
8-K 2018-02-05

Mascota Resources Financials

MASR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703,462,000 4,932,953,000 139,834,000 0 -9,707,897,000 -9,659,520,000 -395,458,000
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240,249,000 43,296,964,000 1,764,009,000 374,238,000 -25,717,337,000 -18,297,230,000 -540,256,000
Poverty Dignified (POVD) 0.0 -4,053% 49,338,000 3,079,595,000 0 0 -1,999,816,000 -1,786,224,000 -40,929,000
Zhong Ya (WLUC) 0.0 0 62,889,000 0 0 -561,596,000 -561,596,000 -2,000
Weyland Tech (WEYL) 18% 2.2 -24% 11,699,111,000 2,217,605,000 24,630,065,000 4,371,806,000 -2,778,623,000 -2,702,174,000 -5,820,631,000
Longbau (LNGB) 4% -1.0 2% 10,659,548,000 10,135,830,000 4,882,008,000 209,757,000 164,602,000 221,914,000 -232,744,000
Scandium International Mining (SCY) 0.1 -171% 956,938,000 303,212,000 0 0 -1,636,126,000 -1,634,396,000 -219,146,000
Aprea Therapeutics (APRE) 8.4 -11% 57,336,058,000 9,942,725,000 0 0 -6,249,419,000 -6,249,419,000 -52,334,104,000
IntelliSense Solutions (INLL) 0.0 -7,286% 2,442,000 272,894,000 0 0 -177,936,000 -163,709,000 -2,444,000
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000,000,000 403,121,000,000,000 37,348,000,000,000 0 4,559,000,000,000 4,960,000,000,000 -8,986,000,001,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4,412,000 323,686,000 0 0 -28,634,000 -17,937,000 -4,414,000
Ando Holdings (ANDO) 1.1 -74% 73,214,000 159,843,000 0 0 -54,299,000 -53,972,000 -60,816,000
Po Yuen Cultural (POYE) 0.0 -1,973% 1,000,000 68,122,000 0 0 -19,731,000 -19,731,000 -2,000
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218,459,000 6,588,633,000 0 0 -701,078,000 -701,078,000 -10,879,000
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,577,822,000 65,986,000 14,700,000 0 -314,665,000 -314,640,000 -238,429,000
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130,000,000 54,472,808,000,000 0 0 132,964,000,000 1,095,234,000,000 32,380,960,999,000
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,276,504,000 5,549,239,000 -688,891,000 1,137,086,000 -4,981,415,000
Original Source Music (OSMU) 0.0 743,400% 35,313,000 0 0 -7,434,000 -7,434,000 -2,000
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076,020,000 1,126,459,000 0 0 0 4,713,000 -2,000
JiaLiJia Group (RZZN) 0.0 -1,721% 4,000,000 139,328,000 0 0 -68,826,000 -68,826,000 -2,000

Balance Sheet ($)2013-11-302014-05-312014-08-312014-11-302015-11-302016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-07-01
Cash1,504,000162,00003,600,0001,172,0001,243,0003,657,0002,546,0002,846,0003,593,00025,700,00018,177,00049,380,0008,034,000
Accounts Receivable
Inventory
PP&E55,000,00055,000,000
Assets12,682,00010,162,00010,000,0003,600,0001,172,0001,243,0003,657,0002,546,00058,593,00080,700,000130,140,000150,543,000151,997,000
Accounts Payable8,718,00012,136,00015,123,0005,393,0009,016,0004,041,0003,841,0004,762,00048,328,00021,205,00027,405,000
Long-Term Debt5,000,00015,216,00015,216,00045,000,00045,000,00045,000,000
Liabilities67,375,00021,806,00027,846,00032,163,00058,907,0009,016,00014,166,00019,128,00020,276,00098,754,000124,257,000167,567,00098,989,000166,353,000
Stockholders' Equity-54,693,000-11,644,000-17,846,000-32,163,000-55,307,000-7,844,000-12,923,000-15,471,000-17,730,000-40,161,000-43,557,000-37,427,00051,554,000-14,356,000
Income Statement ($)2013-11-302014-05-312014-08-312014-11-302015-11-302016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-07-01
Revenue000000
Cost of Revenue
Gross Profit
R&D
SG&A1,061,0001,824,00028,471,0004,954,0002,386,0002,032,00019,468,0006,549,000893,0001,481,00037,185,00015,582,000
Tax000
Net Income-9,027,000-6,202,000-4,317,000-5,079,000-2,548,000-2,259,000-19,828,000-7,603,000-3,396,000-20,701,000-12,396,000-17,451,000
Cash Flow ($)2013-11-302014-05-312014-08-312014-11-302015-11-302016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-07-01
Cash Operating-2,537,000-1,126,000-9,929,000-2,586,000-1,111,000-4,700,000-4,469,000-38,381,000
Cash Investing14,600,000
Cash Financing2,375,0001,126,00010,000,0005,000,00005,000,0005,216,00054,984,000